A rare case of limb girdle muscular dystrophy with predominant scapulo-humeral involvement: diagnostic challenges and multidisciplinary management in a middle-aged male
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20243806Keywords:
LGMD, Proximal muscle weakness, Scapular winging, Electromyography, Resource-limited settings, Multidisciplinary management, Neuromuscular disorders, Patient-centered careAbstract
Limb-girdle muscular dystrophy (LGMD) is a genetically and clinically heterogeneous group of neuromuscular disorders characterized by progressive proximal muscle weakness and varying patterns of scapular winging. Accurate subtype identification is often hindered by diagnostic complexities and limited access to advanced diagnostic tools, particularly in resource-constrained settings. We present the case of a 38-year-old male with a 10-year history of progressive upper limb weakness, scapular winging, and persistent fatigue. Electromyography (EMG) revealed a myopathic pattern, supporting the clinical suspicion of LGMD. Muscle biopsy and genetic testing were not performed due to patient unwillingness and financial limitations. A multidisciplinary management approach comprising low-dose corticosteroids, physiotherapy, and nutritional support led to symptomatic improvement and enhanced functional capabilities. This case underscores the diagnostic challenges posed by the absence of advanced genetic and histopathological investigations and highlights the importance of accessible, patient-centered care. Scapular winging and proximal weakness were pivotal diagnostic features in this case, reflecting the hallmark manifestations of LGMD. The observed improvement with physiotherapy and corticosteroids demonstrates the value of a tailored management strategy in mitigating the impact of this progressive condition. This case emphasizes the need for broader access to diagnostic innovations and advanced therapeutic options to optimize care for patients with rare neuromuscular disorders.
Metrics
References
Angelini C. Limb-girdle muscular dystrophies: heterogeneity of clinical phenotypes and pathogenetic mechanisms. Acta Myol. 2004;23(3):130-6.
Strafella C, Campoli G, Galota RM, Caputo V, Pagliaroli G, Carboni S, et al. Limb-Girdle Muscular Dystrophies (LGMDs): The Clinical Application of NGS Analysis, a Family Case Report. Front Neurol. 2019;18:10. DOI: https://doi.org/10.3389/fneur.2019.00619
Nallamilli BRR, Chakravorty S, Kesari A, Tanner A, Ankala A, Schneider T, et al. Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients. Ann Clin Transl Neurol. 2018;5(12):1574-87. DOI: https://doi.org/10.1002/acn3.649
Fattahi Z, Kalhor Z, Fadaee M, Vazehan R, Parsimehr E, Abolhassani A, et al. Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population. Clin Genet. 2017;91(3):386-402. DOI: https://doi.org/10.1111/cge.12810
Didesch JT, Tang P. Anatomy, Etiology, and Management of Scapular Winging. J Hand Surg. 2019;44(4):321-30. DOI: https://doi.org/10.1016/j.jhsa.2018.08.008
Orrell RW, Copeland S, Rose MR. Scapular fixation in muscular dystrophy. Cochrane Database Syst Rev. 2010;2010(1):CD003278 DOI: https://doi.org/10.1002/14651858.CD003278.pub2
Nguyen C, Guerini H, Zauderer J, Roren A, Seror P, Lefèvre-Colau MM. Magnetic resonance imaging of dynamic scapular winging secondary to a lesion of the long thoracic nerve. Joint Bone Spine. 2016;83(6):747-9. DOI: https://doi.org/10.1016/j.jbspin.2015.11.013
Day J, Patel S, Limaye V. The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies. Semin Arthritis Rheum. 2017;46(5):642-9. DOI: https://doi.org/10.1016/j.semarthrit.2016.11.001
Ghaoui R, Cooper ST, Lek M, Jones K, Corbett A, Reddel SW, et al. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned. JAMA Neurol. 2015;72(12):1424-32. DOI: https://doi.org/10.1001/jamaneurol.2015.2274
Chakravorty S, Hegde M. Clinical Utility of Transcriptome Sequencing: Toward a Better Diagnosis for Mendelian Disorders. Clin Chem. 2018;64(6):882-4. DOI: https://doi.org/10.1373/clinchem.2017.276980
Willis TA, Hollingsworth KG, Coombs A, Sveen ML, Andersen S, Stojkovic T, et al. Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study. PLOS One. 2013 A;8(8):e70993. DOI: https://doi.org/10.1371/journal.pone.0070993
Peterlin B, Gualandi F, Maver A, Servidei S, Maarel SM van der, Lamy F, et al. Genetic testing offer for inherited neuromuscular diseases within the EURO-NMD reference network: A European survey study. PLOS One. 2020;15(9):e0239329. DOI: https://doi.org/10.1371/journal.pone.0239329
Nallamilli BRR, Pan Y, Sniderman King L, Jagannathan L, Ramachander V, Lucas A, et al. Combined sequence and copy number analysis improves diagnosis of limb girdle and other myopathies. Ann Clin Transl Neurol. 2023;10(11):2092-104. DOI: https://doi.org/10.1002/acn3.51896
Chakravorty S, Berger K, Rufibach L, Gloster L, Emmons S, Shenoy S, et al. Combinatorial clinically driven blood biomarker functional genomics significantly enhances genotype-phenotype resolution and diagnostics in neuromuscular disease. BMJ Yale. 2021;14:249850. DOI: https://doi.org/10.1101/2021.01.14.21249850
Martin RM, Fish DE. Scapular winging: anatomical review, diagnosis, and treatments. Curr Rev Musculoskelet Med. 2008;1(1):1-11. DOI: https://doi.org/10.1007/s12178-007-9000-5
Teoh HL, Sampaio H, Roscioli T, Farrar M. Approaches to genetic diagnosis in neuromuscular conditions in the era of next generation sequencing. J Neurol Neurosurg Psychiatry. 2016;87(12):1384-5. DOI: https://doi.org/10.1136/jnnp-2016-313812
Ankala A, Hegde MR, Ankala A, Hegde MR. Advances in Molecular Analysis of Muscular Dystrophies. In: Muscular Dystrophy. IntechOpen. 2012;18. DOI: https://doi.org/10.5772/31578
Siddiqui SH, Ahmed R, Awan S, Zain A, Khan S. Yield of Muscle Biopsy in Patients with Findings of Myopathy on Electrodiagnostic Testing. J Neurosci Rural Pract. 2019;10(3):489-93. DOI: https://doi.org/10.1055/s-0039-1698301
Murphy S, Zweyer M, Mundegar RR, Swandulla D, Ohlendieck K. Proteomic serum biomarkers for neuromuscular diseases. Exp Rev Proteom. 2018;15(3):277-91. DOI: https://doi.org/10.1080/14789450.2018.1429923
Peric M, Peric S, Stevanovic J, Milovanovic S, Basta I, Nikolic A, et al. Quality of life in adult patients with limb-girdle muscular dystrophies. Acta Neurol Belg. 2018;118(2):243-50. DOI: https://doi.org/10.1007/s13760-017-0857-9
Gambhir S, Arumugam N, Kanimozhi D. Early Therapeutic intervention for Limb Girdle Muscular Dystrophy in Late Adolescence–A Case Report. Health Sci. 2016;5(10):182-6.
Trofin D, Matei D, Stamate T, Walther B, Trofin D. Rehabilitation Challenges in Limb-Girdle Muscular Dystrophies. Balneo PRM Res J. 2021;12(1):31-3. DOI: https://doi.org/10.12680/balneo.2021.415
Bengtsson NE, Seto JT, Hall JK, Chamberlain JS, Odom GL. Progress and prospects of gene therapy clinical trials for the muscular dystrophies. Human Mol Genet. 2016;25(R1):R9-17. DOI: https://doi.org/10.1093/hmg/ddv420
Sharma A, Sane H, Gokulchandran N, Gandhi S, Bhovad P, Khopkar D, et al. The role of cell transplantation in modifying the course of limb girdle muscular dystrophy: a longitudinal 5-year study. DNND. 2015;5:93-102. DOI: https://doi.org/10.2147/DNND.S71775
Hunter M, Hatzipolakis A, Heatwole C, Johnson N. Limb-Girdle Muscular Dystrophy: A Perspective from Patients on What Matters Most (P5.450). Neurology. 2018;90(15):P5.450. DOI: https://doi.org/10.1212/WNL.90.15_supplement.P5.450